CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients

Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes,...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 121; no. 5; pp. 1822 - 1826
Main Authors Savoldo, Barbara, Ramos, Carlos Almeida, Liu, Enli, Mims, Martha P., Keating, Michael J., Carrum, George, Kamble, Rammurti T., Bollard, Catherine M., Gee, Adrian P., Mei, Zhuyong, Liu, Hao, Grilley, Bambi, Rooney, Cliona M., Heslop, Helen E., Brenner, Malcolm K., Dotti, Gianpietro
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 01.05.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR+ T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies.
AbstractList Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR+ T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies.
Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR+ T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies.Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR+ T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies.
Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR + T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR + T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies.
Audience Academic
Author Liu, Hao
Rooney, Cliona M.
Brenner, Malcolm K.
Gee, Adrian P.
Heslop, Helen E.
Mims, Martha P.
Savoldo, Barbara
Ramos, Carlos Almeida
Liu, Enli
Dotti, Gianpietro
Kamble, Rammurti T.
Mei, Zhuyong
Bollard, Catherine M.
Grilley, Bambi
Carrum, George
Keating, Michael J.
AuthorAffiliation 1 Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. 2 Department of Pediatrics, Texas Children’s Hospital, Houston, Texas, USA. 3 Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. 4 The Methodist Hospital, Houston, Texas, USA. 5 The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 6 Biostatistics Core of the Dan L. Duncan Cancer Center, Houston, Texas, USA. 7 Department of Virology and 8 Department of Immunology, Baylor College of Medicine, Houston, Texas, USA
AuthorAffiliation_xml – name: 1 Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. 2 Department of Pediatrics, Texas Children’s Hospital, Houston, Texas, USA. 3 Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. 4 The Methodist Hospital, Houston, Texas, USA. 5 The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 6 Biostatistics Core of the Dan L. Duncan Cancer Center, Houston, Texas, USA. 7 Department of Virology and 8 Department of Immunology, Baylor College of Medicine, Houston, Texas, USA
Author_xml – sequence: 1
  givenname: Barbara
  surname: Savoldo
  fullname: Savoldo, Barbara
– sequence: 2
  givenname: Carlos Almeida
  surname: Ramos
  fullname: Ramos, Carlos Almeida
– sequence: 3
  givenname: Enli
  surname: Liu
  fullname: Liu, Enli
– sequence: 4
  givenname: Martha P.
  surname: Mims
  fullname: Mims, Martha P.
– sequence: 5
  givenname: Michael J.
  surname: Keating
  fullname: Keating, Michael J.
– sequence: 6
  givenname: George
  surname: Carrum
  fullname: Carrum, George
– sequence: 7
  givenname: Rammurti T.
  surname: Kamble
  fullname: Kamble, Rammurti T.
– sequence: 8
  givenname: Catherine M.
  surname: Bollard
  fullname: Bollard, Catherine M.
– sequence: 9
  givenname: Adrian P.
  surname: Gee
  fullname: Gee, Adrian P.
– sequence: 10
  givenname: Zhuyong
  surname: Mei
  fullname: Mei, Zhuyong
– sequence: 11
  givenname: Hao
  surname: Liu
  fullname: Liu, Hao
– sequence: 12
  givenname: Bambi
  surname: Grilley
  fullname: Grilley, Bambi
– sequence: 13
  givenname: Cliona M.
  surname: Rooney
  fullname: Rooney, Cliona M.
– sequence: 14
  givenname: Helen E.
  surname: Heslop
  fullname: Heslop, Helen E.
– sequence: 15
  givenname: Malcolm K.
  surname: Brenner
  fullname: Brenner, Malcolm K.
– sequence: 16
  givenname: Gianpietro
  surname: Dotti
  fullname: Dotti, Gianpietro
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21540550$$D View this record in MEDLINE/PubMed
BookMark eNqNks1u1DAQxyNURLcFiSdAFkh8HFJsJ_Y6F6Rq-VpUqRIUrpHXGe-6SuxgO1XLiXfgDXkSHLZdurAH5IOl8W_-45n5H2R71lnIsocEHxEypS8_zOYlJwTfySaEMZELWoi9bIIxJXk1LcR-dhDCOcakLFl5L9unhJWYMTzJvs1eU4GUC9F0QyujcRaZrvfuAgKCy17aMIakbVAPPpgQwSpATiO1Mh14o9JbNEuwyIOCPjr_8_uPzjVGG2jQGVLQtgEZi9qrrl-5TqI-VQEbw_3srpZtgAfX92H2-e2bs9n7_OT03Xx2fJIrjmnMJaNFVclKSq5KqdhCalLqUjOqlaiEpETrkvJyscCiwAs5lZhj3PBKcCg1kOIwe7XW7YdFB41Ktb1s696bTvqr2klTb79Ys6qX7qIukuC0Ykng2bWAd18HCLHuTBj7khbcEGrBGRFTXhWJfPwXee4Gb1N3CeIF54KUCXqyhpayhdpY7VJVNUrWx5RxipnA46_zHVSaM6Qvpu1rk8Jb_NEOPp0GOqN2JrzYSkhMhMu4lEMI9fzTx_9nT79ss09vsSuQbVwF1w6jtcI2-Oj2XjYLuTFnAp6vAeVdCB70BiG4Hn1f3_j-T_cbVJn4281pCqb9N-EXofMCIA
CitedBy_id crossref_primary_10_1007_s12185_013_1493_7
crossref_primary_10_1007_s00262_012_1254_0
crossref_primary_10_1182_bloodadvances_2016000034
crossref_primary_10_1200_JCO_2014_56_2025
crossref_primary_10_1007_s12026_011_8253_7
crossref_primary_10_1146_annurev_cancerbio_050216_034351
crossref_primary_10_2217_imt_2017_0133
crossref_primary_10_12659_MSM_890496
crossref_primary_10_1007_s13238_017_0400_z
crossref_primary_10_1016_S1470_2045_13_70173_6
crossref_primary_10_1016_j_cmet_2022_02_009
crossref_primary_10_1016_j_apsb_2018_03_001
crossref_primary_10_1038_mt_2016_106
crossref_primary_10_1038_gt_2015_4
crossref_primary_10_1007_s10238_024_01347_7
crossref_primary_10_1111_cei_13592
crossref_primary_10_1182_blood_2011_03_344275
crossref_primary_10_3390_cancers13133236
crossref_primary_10_1016_j_molonc_2015_10_012
crossref_primary_10_1158_1078_0432_CCR_13_1016
crossref_primary_10_3390_cancers13051050
crossref_primary_10_1016_j_biopha_2024_117388
crossref_primary_10_1016_j_ymthe_2016_10_016
crossref_primary_10_1073_pnas_1610544113
crossref_primary_10_3390_cancers13102503
crossref_primary_10_1016_j_bbrc_2013_07_030
crossref_primary_10_1080_14712598_2017_1339687
crossref_primary_10_1111_sji_12331
crossref_primary_10_3390_cancers15051357
crossref_primary_10_2217_imt_2017_0026
crossref_primary_10_1016_j_hbpd_2018_05_005
crossref_primary_10_1038_gt_2012_21
crossref_primary_10_1371_journal_pone_0152196
crossref_primary_10_1053_j_seminoncol_2016_02_006
crossref_primary_10_1089_hgtb_2011_199
crossref_primary_10_1177_20406207211017788
crossref_primary_10_1155_2017_5604891
crossref_primary_10_1182_blood_2013_04_493361
crossref_primary_10_1208_s12248_019_0322_1
crossref_primary_10_1089_hum_2018_119
crossref_primary_10_3389_fimmu_2018_02380
crossref_primary_10_1158_1078_0432_CCR_13_2218
crossref_primary_10_1016_j_eng_2021_10_018
crossref_primary_10_3389_fimmu_2017_00457
crossref_primary_10_1016_j_intimp_2024_113717
crossref_primary_10_3390_jcm8020200
crossref_primary_10_1002_jgm_2604
crossref_primary_10_1038_s41416_023_02332_9
crossref_primary_10_1158_2326_6066_CIR_15_0276
crossref_primary_10_1007_s11899_012_0145_y
crossref_primary_10_1038_pcan_2012_49
crossref_primary_10_1016_j_bbmt_2018_03_021
crossref_primary_10_1093_jnci_djv439
crossref_primary_10_1007_s00262_014_1568_1
crossref_primary_10_1016_j_jcyt_2016_07_004
crossref_primary_10_1111_bjh_13340
crossref_primary_10_3324_haematol_2019_231183
crossref_primary_10_1172_JCI86721
crossref_primary_10_1007_s12026_021_09236_x
crossref_primary_10_1016_j_exphem_2018_07_002
crossref_primary_10_1186_s13287_020_02128_1
crossref_primary_10_1517_14712598_2016_1150996
crossref_primary_10_1002_iid3_1091
crossref_primary_10_1182_asheducation_2016_1_390
crossref_primary_10_1016_j_medcle_2020_05_030
crossref_primary_10_1038_cgt_2016_82
crossref_primary_10_3390_ijms20246223
crossref_primary_10_3390_jcm11082158
crossref_primary_10_1126_scitranslmed_abk1900
crossref_primary_10_3390_cancers14061501
crossref_primary_10_3389_fimmu_2020_01704
crossref_primary_10_1007_s11427_016_5036_3
crossref_primary_10_1016_j_ymthe_2017_12_003
crossref_primary_10_1111_bjh_15753
crossref_primary_10_1158_1078_0432_CCR_16_1421
crossref_primary_10_1016_j_celrep_2017_09_015
crossref_primary_10_1038_s41571_021_00476_2
crossref_primary_10_1371_journal_pone_0144787
crossref_primary_10_3390_cancers12040842
crossref_primary_10_1007_s12185_016_2039_6
crossref_primary_10_2139_ssrn_4087366
crossref_primary_10_3390_cancers13215445
crossref_primary_10_1016_j_omto_2021_08_014
crossref_primary_10_1016_j_bbrep_2022_101399
crossref_primary_10_3390_ph8020230
crossref_primary_10_1002_cam4_6497
crossref_primary_10_1007_s11864_020_00772_6
crossref_primary_10_1016_j_addr_2022_114358
crossref_primary_10_3390_cancers14215276
crossref_primary_10_1039_C9AN01811E
crossref_primary_10_1182_blood_2014_01_552174
crossref_primary_10_1016_j_addr_2016_05_019
crossref_primary_10_1200_JCO_2016_71_3024
crossref_primary_10_1007_s00432_023_04996_5
crossref_primary_10_1016_j_omtm_2018_01_009
crossref_primary_10_1080_17843286_2018_1545373
crossref_primary_10_3389_fphar_2014_00235
crossref_primary_10_1016_j_bpj_2023_09_004
crossref_primary_10_1200_JCO_2014_60_3449
crossref_primary_10_1016_j_imlet_2019_06_002
crossref_primary_10_1038_s41586_018_0178_z
crossref_primary_10_1126_science_aaf6756
crossref_primary_10_1200_JCO_20_01749
crossref_primary_10_1016_j_jcyt_2013_10_002
crossref_primary_10_4161_onci_22524
crossref_primary_10_1007_s11427_016_5023_8
crossref_primary_10_1016_j_stem_2015_03_011
crossref_primary_10_1007_s11912_019_0789_z
crossref_primary_10_1089_hum_2012_143
crossref_primary_10_1172_JCI83476
crossref_primary_10_1016_j_trsl_2012_11_002
crossref_primary_10_1126_scitranslmed_3005930
crossref_primary_10_1097_PPO_0000000000000155
crossref_primary_10_1080_17474086_2019_1629901
crossref_primary_10_3389_fonc_2020_608916
crossref_primary_10_1016_j_jcyt_2014_12_002
crossref_primary_10_1097_PPO_0000000000000153
crossref_primary_10_3389_fonc_2019_01529
crossref_primary_10_3390_ijms21103525
crossref_primary_10_1016_j_isci_2024_111669
crossref_primary_10_2217_imt_15_6
crossref_primary_10_1586_ehm_12_38
crossref_primary_10_1038_s41571_021_00530_z
crossref_primary_10_1089_hum_2013_075
crossref_primary_10_1007_s43152_024_00055_4
crossref_primary_10_3389_fimmu_2020_603237
crossref_primary_10_3389_fped_2021_784024
crossref_primary_10_1016_j_jcyt_2019_04_005
crossref_primary_10_1155_2019_5727516
crossref_primary_10_1111_bjh_15851
crossref_primary_10_3390_ijms252212201
crossref_primary_10_1016_j_smim_2020_101437
crossref_primary_10_1038_nm_4478
crossref_primary_10_1038_s41698_022_00272_w
crossref_primary_10_3390_cancers14040967
crossref_primary_10_3390_ijms242115688
crossref_primary_10_1016_j_critrevonc_2020_103031
crossref_primary_10_1182_blood_2013_11_492231
crossref_primary_10_15264_cpho_2020_27_1_14
crossref_primary_10_3389_fimmu_2024_1489827
crossref_primary_10_1189_jlb_5BT1115_524R
crossref_primary_10_22270_jddt_v14i6_6601
crossref_primary_10_1038_cr_2016_154
crossref_primary_10_1111_imr_12774
crossref_primary_10_1080_2162402X_2018_1433518
crossref_primary_10_1038_leu_2015_247
crossref_primary_10_1177_1756284818808086
crossref_primary_10_1371_journal_pone_0031210
crossref_primary_10_1016_j_canlet_2012_09_015
crossref_primary_10_1016_j_canlet_2020_11_044
crossref_primary_10_1080_2162402X_2015_1046673
crossref_primary_10_3389_fimmu_2018_00283
crossref_primary_10_3390_cells11020269
crossref_primary_10_1016_j_ijpharm_2017_07_075
crossref_primary_10_1016_j_canlet_2017_11_005
crossref_primary_10_1021_acsnano_3c10180
crossref_primary_10_1016_j_bulcan_2018_08_002
crossref_primary_10_1182_blood_2013_08_519413
crossref_primary_10_3389_fped_2014_00075
crossref_primary_10_1158_2159_8290_CD_17_0263
crossref_primary_10_1097_PPO_0b013e31824d4465
crossref_primary_10_3389_fimmu_2017_01956
crossref_primary_10_1007_s40472_020_00285_z
crossref_primary_10_1016_j_canlet_2011_10_027
crossref_primary_10_1080_02648725_2018_1430465
crossref_primary_10_3390_ijms22073495
crossref_primary_10_1038_gt_2013_25
crossref_primary_10_1080_17474086_2016_1203251
crossref_primary_10_18632_oncotarget_24179
crossref_primary_10_3109_21691401_2015_1052465
crossref_primary_10_1007_s00262_014_1641_9
crossref_primary_10_1186_bcr3674
crossref_primary_10_3389_fimmu_2018_00199
crossref_primary_10_1586_ehm_12_11
crossref_primary_10_3390_cancers15041015
crossref_primary_10_1002_acg2_54
crossref_primary_10_1007_s10238_017_0450_9
crossref_primary_10_1016_j_jaut_2018_02_006
crossref_primary_10_1097_MOH_0000000000000177
crossref_primary_10_1016_j_transci_2023_103828
crossref_primary_10_1002_jgm_2637
crossref_primary_10_1016_j_ymthe_2017_05_024
crossref_primary_10_1080_14712598_2023_2248878
crossref_primary_10_3390_ijms21197424
crossref_primary_10_1016_j_ymthe_2017_09_005
crossref_primary_10_1016_j_ccell_2019_09_006
crossref_primary_10_1371_journal_pone_0057838
crossref_primary_10_1097_MOH_0000000000000190
crossref_primary_10_1158_1078_0432_CCR_18_1811
crossref_primary_10_1111_ajco_13474
crossref_primary_10_1007_s40259_019_00384_z
crossref_primary_10_1371_journal_pone_0109427
crossref_primary_10_1371_journal_ppat_1009404
crossref_primary_10_1517_14728222_2015_1068759
crossref_primary_10_1051_e3sconf_201913101001
crossref_primary_10_1038_s43018_021_00241_5
crossref_primary_10_1097_PPO_0000000000000166
crossref_primary_10_1371_journal_pone_0063037
crossref_primary_10_1182_blood_2016_02_629063
crossref_primary_10_1586_17474086_2015_1043884
crossref_primary_10_3109_08830185_2015_1018419
crossref_primary_10_1056_NEJMoa1215134
crossref_primary_10_1586_ehm_12_28
crossref_primary_10_1186_s12943_018_0840_y
crossref_primary_10_54097_hset_v36i_5706
crossref_primary_10_1016_j_it_2015_06_004
crossref_primary_10_1007_s12094_023_03122_8
crossref_primary_10_1158_2159_8290_CD_17_1298
crossref_primary_10_3390_cancers14071715
crossref_primary_10_1016_j_jmoldx_2023_06_002
crossref_primary_10_1002_adma_201900192
crossref_primary_10_18632_oncotarget_4071
crossref_primary_10_1155_2017_5210459
crossref_primary_10_1038_s41586_023_05707_3
crossref_primary_10_1016_j_omtm_2022_12_004
crossref_primary_10_3390_cancers13112816
crossref_primary_10_2174_1389450120666191114102830
crossref_primary_10_1631_jzus_B2200256
crossref_primary_10_1016_j_phrs_2021_106036
crossref_primary_10_2147_CMAR_S368588
crossref_primary_10_1182_blood_2012_01_405365
crossref_primary_10_1016_j_addr_2019_01_007
crossref_primary_10_1097_COH_0000000000000284
crossref_primary_10_3892_ijo_2022_5338
crossref_primary_10_1182_blood_2023021243
crossref_primary_10_1002_ijc_28269
crossref_primary_10_1042_BSR20160332
crossref_primary_10_3389_fonc_2024_1394057
crossref_primary_10_1016_j_jconrel_2023_08_033
crossref_primary_10_1016_j_omto_2019_08_008
crossref_primary_10_3389_fimmu_2022_830773
crossref_primary_10_1038_leu_2016_35
crossref_primary_10_1182_blood_2012_12_474056
crossref_primary_10_3389_fimmu_2020_608167
crossref_primary_10_1186_s12896_023_00827_0
crossref_primary_10_1186_s12885_019_5415_9
crossref_primary_10_1016_j_radonc_2022_08_007
crossref_primary_10_1038_nrclinonc_2016_36
crossref_primary_10_1172_jci_insight_92021
crossref_primary_10_3389_fonc_2023_1288383
crossref_primary_10_1016_j_imlet_2019_10_014
crossref_primary_10_1158_1078_0432_CCR_15_1433
crossref_primary_10_1016_j_omton_2024_200814
crossref_primary_10_1007_s11899_017_0398_6
crossref_primary_10_3390_ph7121049
crossref_primary_10_1007_s00262_016_1842_5
crossref_primary_10_1186_s13045_017_0453_8
crossref_primary_10_1208_s12248_025_01017_w
crossref_primary_10_1038_leu_2017_39
crossref_primary_10_3390_ijms222111694
crossref_primary_10_1097_MOP_0000000000000866
crossref_primary_10_1007_s40778_017_0077_5
crossref_primary_10_1097_CM9_0000000000000568
crossref_primary_10_1182_asheducation_V2012_1_143_3798224
crossref_primary_10_4049_jimmunol_1801004
crossref_primary_10_1016_j_copbio_2018_01_025
crossref_primary_10_2217_imt_12_1
crossref_primary_10_1111_tan_12090
crossref_primary_10_1038_mt_2011_223
crossref_primary_10_3389_fimmu_2017_00267
crossref_primary_10_1016_j_coi_2015_01_002
crossref_primary_10_1080_2162402X_2022_2083479
crossref_primary_10_2217_imt_15_23
crossref_primary_10_1182_asheducation_2013_1_348
crossref_primary_10_1200_EDBK_200889
crossref_primary_10_1111_ejh_14052
crossref_primary_10_1017_erm_2021_32
crossref_primary_10_3389_fonc_2020_01428
crossref_primary_10_1089_hgtb_2016_153
crossref_primary_10_1172_JCI177160
crossref_primary_10_3389_fonc_2019_00917
crossref_primary_10_1158_1078_0432_CCR_12_2422
crossref_primary_10_1182_bloodadvances_2022007891
crossref_primary_10_1080_14712598_2020_1727436
crossref_primary_10_3389_fimmu_2019_02664
crossref_primary_10_3390_cancers14163972
crossref_primary_10_1016_j_phrs_2017_11_035
crossref_primary_10_1016_j_ymthe_2025_03_005
crossref_primary_10_2217_imt_13_71
crossref_primary_10_1007_s00262_011_1173_5
crossref_primary_10_1038_nrclinonc_2017_128
crossref_primary_10_1016_j_beha_2017_07_009
crossref_primary_10_1182_blood_2018_01_785840
crossref_primary_10_1016_j_heliyon_2024_e27196
crossref_primary_10_2217_imt_15_16
crossref_primary_10_3390_cancers11020191
crossref_primary_10_1182_blood_2011_10_384388
crossref_primary_10_2217_imt_15_15
crossref_primary_10_2217_imt_15_14
crossref_primary_10_2217_imt_14_44
crossref_primary_10_1016_j_molimm_2017_03_017
crossref_primary_10_1016_j_blre_2015_10_003
crossref_primary_10_1016_j_molimm_2014_12_009
crossref_primary_10_1182_asheducation_2016_1_567
crossref_primary_10_1038_cgt_2015_5
crossref_primary_10_4049_jimmunol_1101585
crossref_primary_10_3390_cancers13010038
crossref_primary_10_3390_ijms19010177
crossref_primary_10_1186_s13045_018_0568_6
crossref_primary_10_1371_journal_pone_0082742
crossref_primary_10_1007_s00432_023_05279_9
crossref_primary_10_1182_blood_2020008221
crossref_primary_10_1200_EDBK_200549
crossref_primary_10_1136_bmjopen_2018_026644
crossref_primary_10_4049_jimmunol_1601494
crossref_primary_10_1016_j_pharmthera_2017_03_008
crossref_primary_10_1073_pnas_1817147116
crossref_primary_10_3389_fimmu_2022_886429
crossref_primary_10_1080_21645515_2019_1689744
crossref_primary_10_3389_fbioe_2022_797440
crossref_primary_10_1016_j_ymthe_2018_01_022
crossref_primary_10_1021_mp500392q
crossref_primary_10_1182_blood_2011_10_381160
crossref_primary_10_1007_s40259_018_0324_z
crossref_primary_10_1111_bjh_12981
crossref_primary_10_1186_s13045_020_00953_8
crossref_primary_10_1146_annurev_med_051914_021702
crossref_primary_10_1038_s41591_018_0036_4
crossref_primary_10_1016_j_tranon_2020_100971
crossref_primary_10_1038_s41551_018_0235_9
crossref_primary_10_1158_1535_7163_MCT_17_1097
crossref_primary_10_1016_j_jaut_2017_08_003
crossref_primary_10_1080_14712598_2022_2026921
crossref_primary_10_1158_2326_6066_CIR_13_0008
crossref_primary_10_1002_mef2_79
crossref_primary_10_1002_advs_201903164
crossref_primary_10_3389_fimmu_2018_02740
crossref_primary_10_3389_fimmu_2018_02861
crossref_primary_10_1111_imr_12139
crossref_primary_10_1007_s12032_018_1149_9
crossref_primary_10_1111_ejh_14103
crossref_primary_10_1111_imr_12136
crossref_primary_10_1111_imr_12130
crossref_primary_10_1111_imr_12131
crossref_primary_10_3389_fbioe_2023_1320807
crossref_primary_10_1007_s11864_020_0706_6
crossref_primary_10_1007_s11899_017_0396_8
crossref_primary_10_3390_cells13090725
crossref_primary_10_3389_fimmu_2023_1253395
crossref_primary_10_1016_j_canlet_2016_12_037
crossref_primary_10_2478_amb_2021_0048
crossref_primary_10_3390_cells11243971
crossref_primary_10_1080_17460441_2024_2319672
crossref_primary_10_2217_imt_2023_0256
crossref_primary_10_1016_j_semcancer_2013_08_011
crossref_primary_10_1016_j_exphem_2019_05_002
crossref_primary_10_1182_asheducation_2013_1_151
crossref_primary_10_3389_fimmu_2018_00239
crossref_primary_10_1016_j_beha_2018_01_002
crossref_primary_10_4254_wjh_v7_i7_980
crossref_primary_10_1053_j_seminhematol_2014_05_006
crossref_primary_10_1182_blood_2011_10_387969
crossref_primary_10_1002_cti2_1421
crossref_primary_10_1111_bjh_17186
crossref_primary_10_1158_2326_6066_CIR_15_0230
crossref_primary_10_3892_mmr_2019_10460
crossref_primary_10_1111_imr_12128
crossref_primary_10_1172_jci_insight_96976
crossref_primary_10_1038_nrclinonc_2016_25
crossref_primary_10_1172_JCI86000
crossref_primary_10_1111_imr_12126
crossref_primary_10_1177_2040620715594736
crossref_primary_10_1007_s40265_019_01071_7
crossref_primary_10_1186_s13045_018_0676_3
crossref_primary_10_1111_imr_12243
crossref_primary_10_1200_JCO_2013_51_5304
crossref_primary_10_7759_cureus_16307
crossref_primary_10_3389_fimmu_2020_01109
crossref_primary_10_1007_s10875_012_9689_9
crossref_primary_10_1016_j_ymthe_2018_09_009
crossref_primary_10_1158_2326_6066_CIR_18_0065
crossref_primary_10_1002_ajh_24238
crossref_primary_10_1016_S0140_6736_14_61729_3
crossref_primary_10_1155_2015_482089
crossref_primary_10_3389_fimmu_2021_681984
crossref_primary_10_1097_CM9_0000000000000638
crossref_primary_10_3389_fcimb_2020_00410
crossref_primary_10_1016_j_ccell_2017_03_002
crossref_primary_10_1111_cas_13239
crossref_primary_10_1371_journal_pone_0130518
crossref_primary_10_1007_s12032_020_01416_3
crossref_primary_10_1371_journal_pone_0093745
crossref_primary_10_1182_blood_2017_02_769208
crossref_primary_10_1146_annurev_cancerbio_061421_012235
crossref_primary_10_3390_biomedicines10081960
crossref_primary_10_1002_med_21818
crossref_primary_10_1126_scitranslmed_abg3072
crossref_primary_10_1007_s12185_012_1037_6
crossref_primary_10_1002_ijc_31147
crossref_primary_10_1007_s00005_023_00683_y
crossref_primary_10_1016_j_beha_2016_08_011
crossref_primary_10_1016_j_bbmt_2014_07_018
crossref_primary_10_3389_fimmu_2023_1142597
crossref_primary_10_1016_S0007_4551_19_30046_3
crossref_primary_10_1016_j_coi_2012_08_007
crossref_primary_10_3109_10428194_2012_727417
crossref_primary_10_1038_cgt_2013_35
crossref_primary_10_1016_j_hoc_2017_06_005
crossref_primary_10_3390_medsci2010023
crossref_primary_10_1111_joim_12020
crossref_primary_10_1158_1078_0432_CCR_14_2998
crossref_primary_10_1186_s12943_018_0814_0
crossref_primary_10_1007_s00277_020_04020_7
crossref_primary_10_1126_scisignal_aay9363
crossref_primary_10_2217_imt_12_143
crossref_primary_10_1038_s41587_022_01639_x
crossref_primary_10_1038_sigtrans_2016_2
crossref_primary_10_1016_j_ymthe_2017_07_013
crossref_primary_10_1038_mt_2014_58
crossref_primary_10_1007_s00262_016_1895_5
crossref_primary_10_2217_imt_2019_0137
crossref_primary_10_3389_fimmu_2023_1063454
crossref_primary_10_1016_j_isci_2023_106443
crossref_primary_10_1016_j_cellsig_2023_110638
crossref_primary_10_1038_srep28208
crossref_primary_10_1002_wnan_1557
crossref_primary_10_1038_nrclinonc_2013_46
crossref_primary_10_1186_ar3909
crossref_primary_10_1182_blood_2014_11_612721
crossref_primary_10_1089_hum_2016_097
crossref_primary_10_2217_fon_14_288
crossref_primary_10_3389_fimmu_2023_1062365
crossref_primary_10_18632_oncotarget_4362
crossref_primary_10_1038_mt_2013_262
crossref_primary_10_1111_bjh_17153
crossref_primary_10_1002_iub_2180
crossref_primary_10_3389_fimmu_2024_1456443
crossref_primary_10_1038_mt_2014_48
crossref_primary_10_3389_fped_2015_00080
crossref_primary_10_1042_BST20150291
crossref_primary_10_1038_bjc_2013_356
crossref_primary_10_1158_1078_0432_CCR_13_0955
crossref_primary_10_1089_hum_2015_054
crossref_primary_10_1016_j_ijbiomac_2025_141364
crossref_primary_10_1177_20406207221080738
crossref_primary_10_1038_s41434_018_0019_6
crossref_primary_10_1016_j_ccell_2019_12_014
crossref_primary_10_1182_blood_2016_04_703751
crossref_primary_10_1371_journal_pone_0159477
crossref_primary_10_1080_14712598_2018_1384463
crossref_primary_10_3892_ijo_2020_4982
crossref_primary_10_1038_s41467_019_10565_7
crossref_primary_10_18632_oncotarget_5582
crossref_primary_10_1016_S0007_4551_19_30045_1
crossref_primary_10_1007_s12185_013_1479_5
crossref_primary_10_1080_2162402X_2020_1846926
crossref_primary_10_1097_CM9_0000000000002476
crossref_primary_10_1097_HS9_0000000000000988
crossref_primary_10_1016_j_jcyt_2024_05_011
crossref_primary_10_1002_jgm_3484
crossref_primary_10_3389_fimmu_2015_00605
crossref_primary_10_1172_JCI129208
crossref_primary_10_1111_imr_13252
crossref_primary_10_1007_s11899_013_0197_7
crossref_primary_10_1007_s40259_021_00473_y
crossref_primary_10_2217_imt_12_33
crossref_primary_10_3390_ijms22042150
crossref_primary_10_1158_2643_3230_BCD_21_0084
crossref_primary_10_1016_j_blre_2019_100645
crossref_primary_10_1186_s13045_019_0758_x
crossref_primary_10_1097_PAT_0b013e32834b6b24
crossref_primary_10_1097_PPO_0000000000000514
crossref_primary_10_1111_bjh_15195
crossref_primary_10_1007_s40778_015_0026_0
crossref_primary_10_1016_j_beha_2018_04_001
crossref_primary_10_1039_C9CS00271E
crossref_primary_10_3892_etm_2018_7015
crossref_primary_10_1182_blood_2013_06_506741
crossref_primary_10_1186_s12929_023_00982_8
crossref_primary_10_1517_14712598_2015_1014792
crossref_primary_10_1016_j_clim_2014_10_002
crossref_primary_10_1056_NEJMc1111004
crossref_primary_10_1038_nrclinonc_2014_177
crossref_primary_10_1080_21645515_2016_1268745
crossref_primary_10_1016_j_hoc_2012_12_004
crossref_primary_10_1038_nm_3833
crossref_primary_10_1016_j_hoc_2023_12_004
crossref_primary_10_1038_nm_3838
crossref_primary_10_1007_s11899_017_0394_x
crossref_primary_10_1158_1078_0432_CCR_18_1211
crossref_primary_10_1007_s11899_016_0336_z
crossref_primary_10_1080_2162402X_2016_1251539
crossref_primary_10_18632_oncotarget_19361
crossref_primary_10_1016_j_heliyon_2023_e21329
crossref_primary_10_1517_14712598_2014_860442
crossref_primary_10_2174_1566523218666181116093857
crossref_primary_10_1186_s13045_019_0704_y
crossref_primary_10_3109_10428194_2012_715350
crossref_primary_10_1002_cti2_1049
crossref_primary_10_1016_j_coche_2012_05_002
crossref_primary_10_1038_leu_2017_57
crossref_primary_10_1158_1078_0432_CCR_14_2675
crossref_primary_10_1007_s41745_018_0062_8
crossref_primary_10_1016_j_clim_2020_108382
crossref_primary_10_1016_j_imlet_2017_08_018
crossref_primary_10_1186_s12985_021_01501_7
crossref_primary_10_1016_j_phrs_2025_107608
crossref_primary_10_1182_blood_2011_12_400044
crossref_primary_10_2217_imt_12_12
crossref_primary_10_1038_gt_2017_81
crossref_primary_10_1182_blood_2015_12_629089
crossref_primary_10_1002_mco2_146
crossref_primary_10_1038_bmt_2015_184
crossref_primary_10_1007_s00432_022_04547_4
crossref_primary_10_1016_j_tranon_2021_101085
crossref_primary_10_1097_CJI_0000000000000199
crossref_primary_10_1016_j_adcanc_2023_100090
crossref_primary_10_3390_cells9030601
crossref_primary_10_1016_j_pan_2020_02_006
crossref_primary_10_1016_j_exphem_2016_07_011
crossref_primary_10_4103_1319_2442_390259
crossref_primary_10_1038_mt_2014_148
crossref_primary_10_1038_mto_2016_14
crossref_primary_10_1182_blood_2015_01_621474
crossref_primary_10_60043_2949_5938_2024_2_10_23
crossref_primary_10_1016_j_molmed_2017_03_002
crossref_primary_10_1177_2399369319863433
crossref_primary_10_1016_j_ymthe_2017_01_011
crossref_primary_10_1007_s12254_021_00703_7
crossref_primary_10_1182_blood_2011_12_398719
crossref_primary_10_1097_HC9_0000000000000022
crossref_primary_10_1038_mt_2013_110
crossref_primary_10_1080_1744666X_2017_1366315
crossref_primary_10_1007_s00005_020_00599_x
crossref_primary_10_1111_bjh_14078
crossref_primary_10_1136_jitc_2022_005519
crossref_primary_10_1134_S1068162017020091
crossref_primary_10_1042_BST20150266
crossref_primary_10_1186_1824_7288_37_46
crossref_primary_10_1016_j_ebiom_2020_102931
crossref_primary_10_1038_mtna_2013_32
crossref_primary_10_1182_blood_2022015728
crossref_primary_10_1186_s40164_020_00190_2
crossref_primary_10_1126_scitranslmed_abb5191
crossref_primary_10_1182_blood_2015_06_650812
crossref_primary_10_1080_08830185_2021_1984449
crossref_primary_10_14338_IJPT_20_00004_1
crossref_primary_10_3389_fimmu_2023_1179827
crossref_primary_10_1586_17474086_2016_1122513
crossref_primary_10_3390_cancers13174279
crossref_primary_10_1016_j_bcmd_2016_11_001
crossref_primary_10_1002_jcb_28250
crossref_primary_10_1007_s12672_024_01638_1
crossref_primary_10_3389_fimmu_2018_00507
crossref_primary_10_3389_fimmu_2018_01717
crossref_primary_10_1097_MOH_0000000000000614
crossref_primary_10_1002_jcp_25419
crossref_primary_10_1371_journal_pone_0199414
crossref_primary_10_1146_annurev_med_060512_150254
crossref_primary_10_1186_s40425_018_0343_9
crossref_primary_10_1007_s00018_022_04421_z
crossref_primary_10_1016_j_currproblcancer_2021_100826
crossref_primary_10_1158_2326_6066_CIR_17_0126
crossref_primary_10_3390_cells9091971
crossref_primary_10_1038_s41587_022_01245_x
crossref_primary_10_1186_1476_4598_13_219
crossref_primary_10_1016_j_ymthe_2020_05_012
crossref_primary_10_1007_s40259_015_0122_9
crossref_primary_10_1016_j_exphem_2016_10_009
crossref_primary_10_1021_acs_jmedchem_0c02054
crossref_primary_10_3389_fimmu_2017_01939
crossref_primary_10_1007_s13402_021_00593_1
crossref_primary_10_1007_s12185_013_1490_x
crossref_primary_10_18632_oncotarget_24637
crossref_primary_10_1038_nrc3565
crossref_primary_10_1038_leu_2016_373
crossref_primary_10_1016_j_canlet_2013_10_004
crossref_primary_10_1016_j_coi_2016_06_004
crossref_primary_10_1016_j_imlet_2013_09_014
crossref_primary_10_1016_j_jcyt_2019_04_060
crossref_primary_10_1042_BST20170178
crossref_primary_10_1182_blood_2017_06_793869
crossref_primary_10_1634_theoncologist_2015_0421
crossref_primary_10_3390_cancers8070064
crossref_primary_10_3389_fmicb_2018_03158
crossref_primary_10_1038_cgt_2014_81
crossref_primary_10_1159_000357163
crossref_primary_10_1016_j_blre_2018_11_002
crossref_primary_10_1177_1758835920962963
crossref_primary_10_3389_fmed_2023_1135468
crossref_primary_10_1016_j_jgg_2017_09_002
crossref_primary_10_1111_sji_13268
crossref_primary_10_3389_fimmu_2016_00500
crossref_primary_10_1038_nrclinonc_2015_187
crossref_primary_10_1016_j_biopha_2019_109685
crossref_primary_10_1002_ajh_27283
crossref_primary_10_1016_j_omto_2022_12_003
crossref_primary_10_1111_trf_14003
crossref_primary_10_1155_2016_5474602
crossref_primary_10_1002_ctm2_70140
crossref_primary_10_3389_fmed_2024_1447147
crossref_primary_10_1002_cnr2_1222
crossref_primary_10_15302_J_QB_021_0253
crossref_primary_10_3109_08880018_2013_802106
crossref_primary_10_1038_nrd4597
crossref_primary_10_1016_j_autrev_2019_02_005
crossref_primary_10_1016_j_imlet_2016_03_007
crossref_primary_10_1038_s41409_019_0604_3
crossref_primary_10_1002_cncr_32764
crossref_primary_10_1134_S0026893317020145
crossref_primary_10_1089_hum_2021_165
crossref_primary_10_3390_vaccines10030457
crossref_primary_10_1016_j_bbmt_2012_10_021
crossref_primary_10_1016_j_intimp_2020_106351
crossref_primary_10_1038_s41375_017_0008_6
crossref_primary_10_1007_s00277_018_3368_8
crossref_primary_10_1158_2326_6066_CIR_14_0186
crossref_primary_10_3389_fimmu_2022_822004
crossref_primary_10_1007_s12185_022_03398_6
crossref_primary_10_1089_hum_2012_202
crossref_primary_10_3390_cancers13164040
crossref_primary_10_3390_v15030789
crossref_primary_10_1186_s13045_017_0437_8
crossref_primary_10_3390_cells8050472
crossref_primary_10_1186_s13643_021_01588_7
crossref_primary_10_3390_ijms22052476
crossref_primary_10_1007_s12185_021_03191_x
crossref_primary_10_3389_fphar_2022_950923
crossref_primary_10_1016_j_leukres_2017_06_011
crossref_primary_10_1016_j_trsl_2017_07_002
crossref_primary_10_1016_j_clml_2022_12_015
crossref_primary_10_1089_hum_2016_025
crossref_primary_10_1158_2159_8290_CD_12_0548
crossref_primary_10_1038_mto_2016_24
crossref_primary_10_1080_14737140_2018_1451749
crossref_primary_10_1016_j_omto_2021_06_006
crossref_primary_10_1038_s41375_020_0930_x
crossref_primary_10_3389_fimmu_2023_1188049
crossref_primary_10_1038_bcj_2016_61
crossref_primary_10_1053_j_seminoncol_2014_08_005
crossref_primary_10_2217_fon_2020_0291
crossref_primary_10_1016_S2152_2650_20_30475_4
crossref_primary_10_1038_s41571_022_00704_3
crossref_primary_10_1111_imm_12784
crossref_primary_10_4049_jimmunol_1302148
crossref_primary_10_1158_1078_0432_CCR_13_0330
crossref_primary_10_2217_imt_2016_0112
crossref_primary_10_7759_cureus_59951
crossref_primary_10_1016_j_phrs_2016_07_019
crossref_primary_10_1042_BST20160037
crossref_primary_10_5402_2012_278093
crossref_primary_10_3109_08830185_2011_595855
crossref_primary_10_1159_000442170
crossref_primary_10_1016_j_mtbio_2023_100615
crossref_primary_10_1371_journal_pone_0061338
crossref_primary_10_3892_ol_2018_8617
crossref_primary_10_1158_2326_6066_CIR_21_0307
crossref_primary_10_1089_hum_2014_045
crossref_primary_10_1016_j_jcyt_2016_05_001
crossref_primary_10_1016_j_smim_2015_12_001
crossref_primary_10_1002_jcp_27599
crossref_primary_10_1016_j_transci_2018_04_019
crossref_primary_10_1186_s40164_024_00553_z
crossref_primary_10_1111_ajt_14185
crossref_primary_10_1182_blood_2013_11_541235
crossref_primary_10_1016_j_beha_2018_05_001
crossref_primary_10_1016_j_intimp_2024_111631
crossref_primary_10_1016_j_bcp_2019_06_002
crossref_primary_10_1016_j_jcyt_2014_02_001
crossref_primary_10_1200_EDBK_180328
crossref_primary_10_1186_s40364_022_00417_w
crossref_primary_10_1007_s00262_015_1757_6
crossref_primary_10_1016_j_jcyt_2013_02_007
crossref_primary_10_3390_ijms21010204
crossref_primary_10_4161_onci_28344
crossref_primary_10_1056_NEJMoa1407222
crossref_primary_10_1182_bloodadvances_2021004535
crossref_primary_10_1038_s41392_019_0070_9
crossref_primary_10_3390_cells9061485
crossref_primary_10_1038_cti_2014_7
crossref_primary_10_1126_scitranslmed_aaa4963
crossref_primary_10_1007_s40265_017_0690_8
crossref_primary_10_1007_s40778_017_0101_9
crossref_primary_10_1016_j_annonc_2021_07_018
crossref_primary_10_1016_j_jcyt_2019_02_013
crossref_primary_10_1038_s41568_022_00491_0
crossref_primary_10_1038_s41598_021_85747_9
crossref_primary_10_1080_14728222_2019_1602608
crossref_primary_10_1186_s12885_018_4817_4
crossref_primary_10_4161_21505594_2014_988098
crossref_primary_10_1126_scitranslmed_aaf8621
crossref_primary_10_4161_hv_27637
crossref_primary_10_1007_s11684_021_0843_8
crossref_primary_10_1186_1756_8722_6_47
crossref_primary_10_1016_j_genrep_2024_101979
crossref_primary_10_1172_JCI186113
crossref_primary_10_2217_imt_2017_0062
crossref_primary_10_1186_s13045_018_0572_x
crossref_primary_10_1016_j_critrevonc_2019_01_015
crossref_primary_10_3390_cancers14051241
crossref_primary_10_3390_cancers15133476
crossref_primary_10_1111_ejh_12602
crossref_primary_10_1155_2014_525913
crossref_primary_10_1017_erm_2015_14
crossref_primary_10_1038_s41467_023_40852_3
crossref_primary_10_1200_JCO_2014_58_0225
crossref_primary_10_1182_blood_2012_02_410373
crossref_primary_10_1111_imr_12812
crossref_primary_10_1038_mt_2014_8
crossref_primary_10_1007_s12094_020_02490_9
crossref_primary_10_1080_14656566_2017_1340938
crossref_primary_10_2217_fon_2021_1090
crossref_primary_10_1038_s41591_019_0737_3
crossref_primary_10_1186_s13045_023_01455_z
crossref_primary_10_1172_JCI94306
crossref_primary_10_1016_j_tracli_2015_05_002
crossref_primary_10_3389_fimmu_2021_670286
crossref_primary_10_2217_imt_2017_0072
crossref_primary_10_22159_ajpcr_2024v17i7_50815
crossref_primary_10_1007_s12094_024_03774_0
crossref_primary_10_1111_bjh_14475
crossref_primary_10_1186_1756_8722_6_33
crossref_primary_10_1016_j_medcli_2020_05_007
crossref_primary_10_1038_s41419_024_06734_2
crossref_primary_10_1111_j_1399_0039_2011_01799_x
crossref_primary_10_3389_fmolb_2021_756599
crossref_primary_10_1016_j_trsl_2017_06_003
crossref_primary_10_1517_14712598_2014_920813
crossref_primary_10_1186_s40425_017_0223_8
crossref_primary_10_2174_0109298673268932230920063933
crossref_primary_10_1111_bjh_14470
crossref_primary_10_1016_j_nec_2020_06_014
crossref_primary_10_1158_0008_5472_CAN_14_1530
crossref_primary_10_1586_1744666X_2014_865519
crossref_primary_10_1080_14712598_2024_2404100
crossref_primary_10_1177_2040620719841581
crossref_primary_10_2217_imt_12_162
crossref_primary_10_1016_j_cdtm_2018_08_002
crossref_primary_10_1016_S2352_3026_19_30115_2
crossref_primary_10_3389_fimmu_2018_03180
crossref_primary_10_1126_scitranslmed_3002842
crossref_primary_10_1016_j_trsl_2017_06_011
crossref_primary_10_1080_14712598_2018_1384810
crossref_primary_10_1172_JCI80010
crossref_primary_10_1200_JCO_2014_57_5472
crossref_primary_10_1016_j_cpt_2022_12_002
crossref_primary_10_1097_MS9_0000000000001375
crossref_primary_10_1038_mt_2014_208
crossref_primary_10_2217_imt_11_135
crossref_primary_10_1038_bmt_2011_155
crossref_primary_10_1002_cpt_392
crossref_primary_10_1080_13543784_2022_2032642
crossref_primary_10_1158_0008_5472_CAN_14_0697
crossref_primary_10_3389_fimmu_2023_1260470
crossref_primary_10_1038_cgt_2012_74
crossref_primary_10_1186_s40425_018_0347_5
crossref_primary_10_1038_mt_2015_119
crossref_primary_10_1038_nature22395
crossref_primary_10_1158_2326_6066_CIR_14_0127
crossref_primary_10_1007_s00262_021_03009_z
Cites_doi 10.1200/JCO.2006.09.2403
10.1073/pnas.0813101106
10.1182/blood-2010-04-281931
10.1182/blood-2007-05-091280
10.1158/1078-0432.CCR-06-1183
10.1038/nrc1586
10.1038/nri2635
10.1016/j.bbmt.2010.03.014
10.1038/sj.leu.2403302
10.1200/JCO.2005.00.240
10.1016/j.ymthe.2005.04.016
10.1126/science.1129003
10.1038/nrc2355
10.1038/nri727
10.1073/pnas.90.2.720
10.1038/ni0302-221
10.1016/S0161-5890(97)00144-2
10.1038/nm.1882
10.1038/nm827
10.1182/blood-2007-12-128843
10.1182/blood-2010-01-043737
10.1016/j.coi.2009.02.009
10.1038/nbt0102-70
10.1182/blood-2002-07-1989
10.1182/blood-2006-04-017061
ContentType Journal Article
Copyright COPYRIGHT 2011 American Society for Clinical Investigation
Copyright American Society for Clinical Investigation May 2011
Copyright © 2011, American Society for Clinical Investigation
Copyright_xml – notice: COPYRIGHT 2011 American Society for Clinical Investigation
– notice: Copyright American Society for Clinical Investigation May 2011
– notice: Copyright © 2011, American Society for Clinical Investigation
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7RV
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
S0X
7X8
5PM
DOI 10.1172/JCI46110
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Nursing & Allied Health Database (Proquest)
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
eLibrary Curriculum
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Health & Medical Collection
Proquest Medical Database
Biological Science Database (Proquest)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
SIRS Editorial
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
SIRS Editorial
elibrary
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-8238
EndPage 1826
ExternalDocumentID PMC3083795
2346315351
A256205801
21540550
10_1172_JCI46110
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: 3P50CA126752
– fundername: NCI NIH HHS
  grantid: P30 CA125123
– fundername: NCI NIH HHS
  grantid: P50 CA126752
– fundername: NCI NIH HHS
  grantid: P01 CA094237
GroupedDBID ---
-~X
.55
.XZ
08G
08P
29K
354
36B
5GY
5RE
5RS
7RV
7X7
88E
8AO
8F7
8FE
8FH
8FI
8FJ
8R4
8R5
AAWTL
AAYOK
AAYXX
ABOCM
ABPMR
ABUWG
ACGFO
ACIHN
ACNCT
ACPRK
ADBBV
AEAQA
AENEX
AFCHL
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BCR
BCU
BEC
BENPR
BHPHI
BKEYQ
BLC
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D-I
DIK
DU5
E3Z
EBD
EBS
EJD
EMB
EMOBN
EX3
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
IOF
IOV
IPO
ISR
ITC
KQ8
L7B
LK8
M1P
M5~
M7P
NAPCQ
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OK1
OVD
OVIDX
OVT
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
RPM
S0X
SJFOW
SV3
TEORI
TR2
TVE
UKHRP
VVN
W2D
WH7
WOQ
WOW
X7M
XSB
YFH
YHG
YKV
YOC
ZY1
~H1
.GJ
2WC
3O-
53G
AAKAS
ADZCM
AFFNX
AI.
CGR
CUY
CVF
ECM
EIF
FEDTE
HVGLF
H~9
J5H
MVM
N4W
NPM
OHT
PJZUB
PPXIY
PQGLB
UHU
VH1
ZGI
ZXP
PMFND
3V.
7XB
88A
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c602t-a52399a9aa6c4ac5baf14f4f52fc898a21ff4264bb0830ba7a0600d6986e4fe13
IEDL.DBID 7X7
ISSN 0021-9738
1558-8238
IngestDate Thu Aug 21 18:28:40 EDT 2025
Fri Jul 11 05:37:08 EDT 2025
Fri Jul 25 19:18:04 EDT 2025
Tue Jun 17 21:34:57 EDT 2025
Thu Jun 12 23:26:39 EDT 2025
Tue Jun 10 20:25:43 EDT 2025
Fri Jun 27 04:37:55 EDT 2025
Fri Jun 27 03:43:09 EDT 2025
Thu May 22 21:08:57 EDT 2025
Mon Jul 21 06:06:39 EDT 2025
Tue Jul 01 00:54:19 EDT 2025
Thu Apr 24 22:57:20 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c602t-a52399a9aa6c4ac5baf14f4f52fc898a21ff4264bb0830ba7a0600d6986e4fe13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Feature-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.jci.org/articles/view/46110/files/pdf
PMID 21540550
PQID 866366814
PQPubID 42166
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3083795
proquest_miscellaneous_865187693
proquest_journals_866366814
gale_infotracmisc_A256205801
gale_infotracgeneralonefile_A256205801
gale_infotracacademiconefile_A256205801
gale_incontextgauss_ISR_A256205801
gale_incontextgauss_IOV_A256205801
gale_healthsolutions_A256205801
pubmed_primary_21540550
crossref_primary_10_1172_JCI46110
crossref_citationtrail_10_1172_JCI46110
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-05-01
PublicationDateYYYYMMDD 2011-05-01
PublicationDate_xml – month: 05
  year: 2011
  text: 2011-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Ann Arbor
PublicationTitle The Journal of clinical investigation
PublicationTitleAlternate J Clin Invest
PublicationYear 2011
Publisher American Society for Clinical Investigation
Publisher_xml – name: American Society for Clinical Investigation
References B20
B21
B22
B23
B24
B25
Brentjens (B18) 2003; 9
B10
B11
B12
B13
B14
B15
B16
B17
B19
B1
B2
B3
B4
B5
B6
B7
B8
B9
22091680 - Immunotherapy. 2011 Dec;3(12):1441-3. doi: 10.2217/imt.11.135.
References_xml – ident: B24
  doi: 10.1200/JCO.2006.09.2403
– ident: B14
  doi: 10.1073/pnas.0813101106
– ident: B8
  doi: 10.1182/blood-2010-04-281931
– ident: B2
  doi: 10.1182/blood-2007-05-091280
– ident: B10
  doi: 10.1158/1078-0432.CCR-06-1183
– ident: B11
  doi: 10.1038/nrc1586
– ident: B6
  doi: 10.1038/nri2635
– ident: B19
  doi: 10.1016/j.bbmt.2010.03.014
– ident: B13
  doi: 10.1038/sj.leu.2403302
– ident: B20
  doi: 10.1200/JCO.2005.00.240
– ident: B15
  doi: 10.1016/j.ymthe.2005.04.016
– ident: B21
  doi: 10.1126/science.1129003
– ident: B1
  doi: 10.1038/nrc2355
– ident: B22
  doi: 10.1038/nri727
– ident: B4
  doi: 10.1073/pnas.90.2.720
– ident: B23
  doi: 10.1038/ni0302-221
– ident: B16
  doi: 10.1016/S0161-5890(97)00144-2
– ident: B3
  doi: 10.1038/nm.1882
– volume: 9
  start-page: 279
  year: 2003
  ident: B18
  publication-title: Nat Med.
  doi: 10.1038/nm827
– ident: B9
  doi: 10.1182/blood-2007-12-128843
– ident: B7
  doi: 10.1182/blood-2010-01-043737
– ident: B5
  doi: 10.1016/j.coi.2009.02.009
– ident: B12
  doi: 10.1038/nbt0102-70
– ident: B17
  doi: 10.1182/blood-2002-07-1989
– ident: B25
  doi: 10.1182/blood-2006-04-017061
– reference: 22091680 - Immunotherapy. 2011 Dec;3(12):1441-3. doi: 10.2217/imt.11.135.
SSID ssj0014454
Score 2.5756667
Snippet Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1822
SubjectTerms Antigens
Antigens, CD19 - metabolism
Biomedical research
Brief Report
Care and treatment
CD28 Antigens - metabolism
Cell receptors
Development and progression
Female
Human subjects
Humans
Immunophenotyping
Immunotherapy
Immunotherapy - methods
Lymphocyte Activation
Lymphocytes
Lymphoma
Lymphoma - metabolism
Lymphoma, B-Cell - metabolism
Lymphoma, Non-Hodgkin - metabolism
Lymphomas
Male
Middle Aged
Patients
Physiological aspects
Positron-Emission Tomography - methods
Protein Structure, Tertiary
Retroviridae - genetics
T cells
T-Lymphocytes - metabolism
Tomography, X-Ray Computed - methods
Title CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
URI https://www.ncbi.nlm.nih.gov/pubmed/21540550
https://www.proquest.com/docview/866366814
https://www.proquest.com/docview/865187693
https://pubmed.ncbi.nlm.nih.gov/PMC3083795
Volume 121
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1NT9wwELUoSFUvVaFfKZS6VVVOEets_JFTBQuIpYJWFKq9RY5jQyQ22Ta7Ev33nUm80aZCVY-RX6TEHnuex-M3hHzMwGtrHYkwZzYL40jiZeVchhq4LDfcSOswDnl-IU6v47MJn_jcnNqnVS7XxGahziuDMfJ9Ba5RCMXiz7OfIRaNwsNVX0HjEdlA5TLM6JKTbr8FWwXuRZhZmMih8tqz4LL3z0bjWDC8Nrvijf5ek1ecUj9hcsUDnTwjTz11pAftWG-SNVtukcfn_nD8ObkfHUWKmgom7dQX5aJFEzOwNbX3MO0xMkZ1mdMZRsnqhi7TylFzWzQHN9A2R3VOCsugncFuPJxWeeGApdIriiH-mhYlvfsNFlBNNfWarPULcn1yfDU6DX1hhdCIQTQPNccbrTrRWphYG55px2IXOx45oxKlI-YcMqUsA4I2yLTUA-BFuUiUsLGzbPiSrJdVaV8TyhzTXJo80Vi7mgHBiLJEKwO7FCesSgKyt-zg1HjVcSx-cZc2uw8ZpcuhCMj7DjlrlTYewLzDMUrbO6Ld5EwPgLhFAw7eNiAfGgRKW5SYO3OjF3Wdjr_--A_Q98seaM-DXAVfbLS_rwD_jZJZPeSnHvKmFQx_CLjTA8JMNr3m7aXppX4lqdPO7gNCu1Z8EZPjSlstEMKZwpqWAXnV2mnXgUDogJFz6DjZs-AOgOri_ZayuG1Uxocw9jLhb_75UdvkSRtkxwzQHbI-_7Wwb4GlzbPdZi7uko3D44tvl_B0NP7yBwKqPvg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEvE990G8wgYE_RajfOxwNCo9vUbmtBo5v2FhzH3iqtSSGt2P4o_kfuEidq0IR42bN_jVL7cve7830Q8i4Gqy0l95yE6dhxuY_FyonvSOCyQgnla4NxyOHI65-6h-fifIX8rmphMK2y0omFok4yhTHynQBMo-cFzP00--Hg0Ci8XK0maJRScaRvfoHHln8c7MHxvuf8YH_c6zt2qICjvA6fO1JgNacMpfSUK5WIpWGucY3gRgVhIDkzBllCHAM56cTSlx3gBIkXBp52jWZdeO49sup2wZNpkdXP-6OvJ_W1hesK2_aZOaHfDWy3WyAJO4e9gesxLNRdsn9_W4ElM9hM0VyyeQePyJolq3S3lK7HZEWnT8j9ob2Of0que3s8oCoDNTG1Y8DopIhS6Jzqa1A0GIujMk3oDONyeUHQaWaoupwUV0WwNsd-oBQUr56B_-9Ms2RigBfTMcVLhZxOUnp1AzKXTSW1XWDzZ-T0Tnb9OWmlWapfEsoMk8JXSShxWjYDSsPjUAYK_CLj6SBsk-1qgyNl-5zjuI2rqPB3fB5VR9Emb2rkrOztcQtmC88oKqtSa3UQ7QJV5B0B9r1N3hYIbKaRYrbOhVzkeTT4cvYfoG8nDdC2BZkM3lhJWyEB_xubdDWQHxrIi7JF-W3AzQYQdIdqLG9UohdZ3ZVH9ZfWJrRexR9iOl6qswVCBAtwimabvCjltN5AoJDgAwjYOL8hwTUA-5k3V9LJZdHXvAtn74di_Z8vtUUe9MfD4-h4MDraIA_LED_mn26S1vznQr8CjjiPX9svk5Lvd60M_gBnWXsQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwELbGkCZeEL8pG8wgYE9RazeOkweEppZq3dhAsKG-ZY5jb5XWpCyt2P40_jvuEidq0IR42bO_RIl9vvvu7Lsj5G0CVlspHngpM4nnc4nJyqn0FHBZoYWWxmIc8vAo2Dvx9ydiskZ-17kweK2y1omlok5zjTHybgimMQhC5netuxXxdTj6OP_pYQMpPGitu2lUEnJgrn-B91Z8GA9hqd9xPvp0PNjzXIMBTwc9vvCUwMxOFSkVaF9pkSjLfOtbwa0Oo1BxZi0yhiQBotJLlFQ94AdpEIWB8a1hfXjvHXJX9gXDLSYnja8HbopwBaCZF8l-6OreAl3o7g_GfsAwZXfFEv5tD1YMYvuy5or1Gz0g9x1tpbuVnD0kayZ7RDYO3cH8Y3I1GPKQ6hwUxsw1BKPTMl5hCmquQOVgVI6qLKVzjNAVJVWnuaX6fFoeGsHYAiuDUlDBZr7IL71Znk4tMGR6TPF4oaDTjF5cg_TlM0VdPdjiCTm5lTl_StazPDPPCWWWKSF1Ginsm82A3PAkUqEGD8kGJow6ZKee4Fi7iufYeOMiLj0fyeN6KTrkdYOcV1U-bsBs4xrFVX5qoxjiXSCNvCfA0nfImxKBZTUylNAztSyKePzlx3-Avn9rgXYcyObwxVq5XAn4byzX1UK-byHPqmLlNwG3WkDQIro1vFmLXuy0WBE3e65DaDOKD-LFvMzkS4QIFmI_zQ55VslpM4FAJsEbEDBxsiXBDQArm7dHsul5WeG8D2svI_Hinx-1TTZABcSfx0cHm-ReFevHi6hbZH1xuTQvgSwuklfltqTk9Lb1wB-xvn3g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD28+costimulation+improves+expansion+and+persistence+of+chimeric+antigen+receptor-modified+T+cells+in+lymphoma+patients&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Savoldo%2C+Barbara&rft.au=Ramos%2C+Carlos+Almeida&rft.au=Liu%2C+Enli&rft.au=Mims%2C+Martha+P&rft.date=2011-05-01&rft.pub=American+Society+for+Clinical+Investigation&rft.issn=0021-9738&rft.volume=121&rft.issue=5&rft.spage=1822&rft_id=info:doi/10.1172%2FJCI46110&rft.externalDBID=ISR&rft.externalDocID=A256205801
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon